AWAU
GILD icon

Alliance Wealth Advisors (Utah)’s Gilead Sciences GILD Stock Holding History

Alliance Wealth Advisors (Utah)’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.21M Sell
9,579
-3,768
-28% -$496K 0.23% 58
2026
Q1 		$1.86M Sell
13,347
-6,364
-32% -$891K 0.4% 41
2025
Q4 		$2.42M Sell
19,711
-9,157
-32% -$1.11M 0.52% 54
2025
Q3 		$3.2M Sell
28,868
-523
-2% -$59.4K 0.75% 41
2025
Q2 		$3.26M Buy
29,391
+705
+2% +$75K 0.78% 43
2025
Q1 		$3.21M Sell
28,686
-333
-1% -$34.4K 0.84% 40
2024
Q4 		$2.68M Sell
29,019
-138
-0.5% -$12.4K 0.69% 54
2024
Q3 		$2.44M Buy
29,157
+1,853
+7% +$141K 0.64% 56
2024
Q2 		$1.87M Buy
27,304
+830
+3% +$55.4K 0.55% 55
2024
Q1 		$1.94M Buy
26,474
+2,482
+10% +$191K 0.58% 53
2023
Q4 		$1.94M Buy
23,992
+2,938
+14% +$229K 0.65% 52
2023
Q3 		$1.58M Buy
21,054
+1,075
+5% +$82.7K 0.58% 55
2023
Q2 		$1.54M Buy
19,979
+704
+4% +$56.1K 0.57% 58
2023
Q1 		$1.6M Buy
19,275
+604
+3% +$50K 0.64% 51
2022
Q4 		$1.6M Buy
+18,671
New +$1.48M 0.72% 50

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Alliance Wealth Advisors (Utah)'s GILD Position: Q2 2026 in Review

Alliance Wealth Advisors (Utah) reduced its Gilead Sciences (GILD) stake by 28% in Q2 2026, selling an estimated $496K and leaving 9,579 shares worth $1.21M. The position accounts for 0.23% of the portfolio, ranked #58.

Alliance Wealth Advisors (Utah) first reported a position in GILD in Q4 2022 and has held it in 15 quarters since. The position peaked at $3.26M in Q2 2025. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Alliance Wealth Advisors (Utah) held 9,579 shares of Gilead Sciences worth $1.21M as of Q2 2026.
  • Alliance Wealth Advisors (Utah) sold 3,768 Gilead Sciences shares in Q2 2026, an estimated $496K.
  • Gilead Sciences made up 0.23% of Alliance Wealth Advisors (Utah)'s portfolio in Q2 2026, its #58 holding.
  • Alliance Wealth Advisors (Utah) first reported a position in Gilead Sciences in Q4 2022 and has held it in 15 quarters since.
  • Alliance Wealth Advisors (Utah)'s Gilead Sciences position peaked at $3.26M in Q2 2025.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Alliance Wealth Advisors (Utah)'s 13F filing for Q2 2026, filed 23 Jul 2026.